Trinity Biotech (TRIB) Short-Term Debt repayments (2022 - 2024)

Trinity Biotech has disclosed Short-Term Debt repayments across 3 years of filings, most recently posting -$75000.0 for Q4 2024.

• In Q4 2024, Short-Term Debt repayments changed 0.0% year-over-year to -$75000.0; the TTM figure through Dec 2024 stood at -$300000.0 (changed 0.0% YoY), while the FY2025 annual figure was -$300000.0, changed 0.0% from the prior year.
• Short-Term Debt repayments came in at -$75000.0 for Q4 2024 at Trinity Biotech, roughly flat from -$75000.0 in the prior quarter.
• In the past five years, Short-Term Debt repayments ranged from a high of -$49000.0 in Q2 2022 to a low of -$75000.0 in Q3 2022.
• Average Short-Term Debt repayments over 3 years is -$72636.4, with a median of -$75000.0 recorded in 2022.
• The largest YoY upside for Short-Term Debt repayments was 0.0% in 2023 against a maximum downside of 53.06% in 2023.
• Over 3 years, Short-Term Debt repayments stood at -$75000.0 in 2022, then changed by 0.0% to -$75000.0 in 2023, then changed by 0.0% to -$75000.0 in 2024.
• Per Business Quant data, the three most recent Short-Term Debt repayments figures were -$75000.0 in Q4 2024, -$75000.0 in Q3 2024, and -$75000.0 in Q2 2024.